In a study published in The Oncologist conducted by UNC and the Vall d’Hebron Institute of Oncology in Barcelona, Spain, a team lead by Charles Perou, PhD, of UNC Lineberger Comprehensive Cancer Center, examined more than 1,700 breast tumors, including 412 triple negative (TN) breast cancers, and concluded that triple-negative cancers, and basal-like breast cancers should not be considered as a single type, since more than 30 percent of triple-negative cancers lack biological markers associated with basal-like tumors. Read more here.
Study mentioned: Prat A, et al. Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers. Oncologist. 2013 Feb 12. [Epub ahead of print] PMID: 23404817
No comments:
Post a Comment